RXO: financial statements from SEC — TradeAlmanac

RXO

RXO, Inc.: financial statements

Company reports as filed with the U.S. Securities and Exchange Commission.

AnnualQuarterly

Income statement

Metric	Dec 31, 2025	Dec 31, 2024
Revenue	5.74bn	4.55bn
Cost of revenue	4.61bn	3.57bn
Selling, general and administrative	832m	666m
Operating income	−79m	−56m
Pre-tax income	−115m	−304m
Income tax	−15m	−14m
Net income	−100m	−290m
Earnings per share	−0.59	−2.17
Earnings per share, diluted	−0.59	−2.17
Weighted average shares	168m	133m
Weighted average shares, diluted	168m	133m

Balance sheet

Metric	Mar 31, 2026	Dec 31, 2025	Sep 30, 2025	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024
Cash and equivalents	21m	17m	25m	18m	16m	35m	55m	7m
Receivables	1.22bn	1.23bn	1.10bn

Cash flow

Metric	Dec 31, 2025	Dec 31, 2024
Operating cash flow	51m	−12m
Depreciation and amortisation	116m	87m
Share-based compensation	29m	23m
Capital expenditure	59m	45m
Investing cash flow	−71m	−1.06bn
Share buybacks	0

Amounts in USD unless stated otherwise. Sources: Nasdaq Trader, Yahoo Finance, U.S. Securities and Exchange Commission (EDGAR)